The development of antimicrobial resistance (AMR) in pathogenic microorganisms is a major public health threat. To prevent this from happening, we need to minimize the use of antibiotics globally.

Tackling the threat of AMR is considered critical to achieving the Sustainable Development Goals (SDGs) by the Food and Agriculture Organization (FAO). Dutch livestock farms have already managed to reduce their antibiotic use by >90%. At our first international conference, we will share our best practices.

Let's beat AMR with HyCare - logo
Arrow - iconCheck out our events


JANUARY 10 2022
Reducing antimicrobial use in European livestock production


Experts have discussed trends and developments in AMR, best practices, key insights and local developments. This conference was organized in collaboration with the Healthy Livestock project (EU and China). We have shared our experiences in reducing antibiotic use with HyCare management at livestock farms. In total, 253 registrants from 54 different countries showed their interest in the online conference.

Download the press release for more information

Video thumbnail
Recording of the online conference.
Duration: 3.23 hr.
June 23 2022

It's time for Bologna to take the stage again

Science meets practice to reduce the need for antimicrobials


Together with partners we organize a live event in Bologna for businesses, science & research institutes and governmental bodies. We zoom in with a scientific eye on all kinds of developments we see happening in practice.

The time for action is now!

Keep me informed
Healthy Livestock logo
Video thumbnail
Video thumbnail
The role of agriculture in preventing the development of antimicrobial resistance.
Duration: 3.36 min.
What is Antimicrobial Resistance (AMR)?

Antimicrobial Resistance occurs when bacteria, viruses, fungi, and parasites change over time and no longer respond to medicines, making infections harder to treat and increasing the risk of disease, severe illness, and death.

As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become increasingly difficult or impossible to treat. Put simply, the more antibiotics we use, the faster and stronger resistance will develop in microbes.

Euro icon
billion Euro

Currently avoidable healthrelated costs due to AMR.

Deaths - icon
million deaths

If we do nothing, up to 10 million people will die annually by AMR, beating cancer as #1 cause of death.

Dollar - icon
trillion USD

Additional health expenditure per year expected by 2050 due to the rise of AMR.

How Dutch farmers reduced the use of antibiotics

In the Netherlands, the use of antibiotics in the livestock sector has been reduced by more than 70% since 2009. This has been made possible by shifting the focus on disease prevention, as healthy animals do not need a cure. A major contributor to any disease prevention program is hygiene. During this time we developed our HyCare management method: to help livestock companies across the globe manage their hygiene practices through a standardized method that leads to the highest level of results.

Learn more about HyCare
Graph - Use of antibiotics in livestock farming
What do I need to know about AMR?

Antimicrobial resistance (AMR) is a global health and development threat. It requires urgent multi sectoral action.

WHO has declared that AMR is one of the top 10 global public health threats facing humanity.

Lack of clean water and sanitation and inadequate infection prevention and control promotes the spread of microbes, some of which can be resistant to antimicrobial treatment.

The cost of AMR to the economy is significant. In addition to death and disability, prolonged illness results in longer hospital stays, the need for more expensive medicines and financial challenges for those impacted.

Without effective antimicrobials, the success of modern medicine in treating infections, including during major surgery and cancer chemotherapy, would be at increased risk.

Misuse and overuse of antimicrobials are the main drivers in the development of drug-resistant pathogens.

Download our whitepaper about AMR

Download our whitepaper about AMR if you want to know more in-depth about the subject. Written by Dr. Ing. J. van den Borne (NL)

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Contact us

Call for personal advice +31 (0)497 339 787 or send an email to

Follow us on social media
Visit us

The Schippers Group
Smaragdweg 60
5527 LB Hapert

Let's beat AMR with HyCare - logo

More information about our mission

Check it out
HyCare logo

Our solution to AMR

Read more
Search - icon

Check out our career opportunities